Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis (PROLIV)
Prognostic Value of Liver Volume on Acute Decompensation of Alcoholic Cirrhosis, a Prospective Multicenter Observational Study
Sponsor: Narbonne Hospital
Terminated
inclusion number not sufficient
Other Alcoholic Cirrhosis trials with similar outcome
Listed as NCT03508388, this observational or N/A phase trial focuses on Alcoholic Cirrhosis and Alcoholic Liver Disease and remains terminated or withdrawn. Sponsored by Narbonne Hospital, it has been updated 9 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2023 — Jul 2024 [monthly]
Terminated
Status: Unknown Status → Terminated
-
Mar 2022 — Jan 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Recruiting
-
Jun 2018 — Jan 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Narbonne Hospital
- University Hospital, Montpellier
- University Hospital, Nīmes
For direct contact, visit the study record on ClinicalTrials.gov .